Remove Cardiology Remove Clinical Trials Remove DNA Remove Radiology
article thumbnail

Unveiling Potential: Exploring Alpha Emitter Radiopharmaceuticals

XTalks

Currently, several alpha particle emitters are being investigated in clinical trials. When alpha-emitting radionuclides are delivered to cancer cells, the emitted alpha particles cause substantial damage to the DNA of the cells, leading to cell death. Guarnaschelli in the webinar.

DNA 66